Our mission is to study and treat cancer in companion animals. In so doing, our work facilitates numerous opportunities for valuable comparative cancer investigations that can also contribute to improving human health. Our mission is supported by a three-pronged approach with efforts committed to discovery, translational investigation, and contemporary clinical care for companion animals with cancer.   


  • Decipher mechanisms associated with malignant transformation in cancer in pet animals
  • Increase our understanding of dysregulated processes in cancer cells:
    • promote identification of new treatment opportunities
    • explain/understand why things don't work
    • develop rational basis to explore novel therapeutic concepts through basic investigation of biological systems
  • Efforts supported through the oncology research laboratory

Translational Investigation

  • Address critical problems in veterinary clinical oncology
    • immediate need to improve the standard of care
    • improve laboratory cancer diagnostics: cell based, molecular, biomarkers
  • Evaluate promising new treatments for human cancer patients in companion animal cancer
    • expand treatment options and improve health of animals with cancer
    • increase our understanding of the treatment for humans in natural animal models

Clinical Care

  • Provide state-of-the-art care for companion animals with cancer in the Veterinary Teaching Hospital
    • a resource for accurate information about animal cancer for pet owners and referring veterinarians
    • clarify treatment options for pet owners
    • coordinated medical and surgical oncology services
    • enroll animal cancer patients in clinical trials that evaluate new treatment:
      • state-of-the-art tumor imaging;
      • 64-slice CT scanner;
      • intraoperative radiotheray system
      • nuclear scintigraphy;
      • osteosarcoma limb-spare surgery


Surgical Oncology

Gastrointestinal Oncology

Clinical Pathology

Anatomic Pathology

    Oncology Research Laboratory



    Strategic Alliances

    Oregon State University 

    Siva Kolluri
    Department of Environmental & Molecular Toxicology
    Reasearch Interest: aryl hydrocarbon receptors as cancer triggers

    Russell Turner
    Health & Human Sciences
    Bone Research Laboratory
    Reseach Interest: osteosarcoma

    Urszula T. Iwaniec
    Health & Human Sciences
    Bone Research Laboratory
    Research Interest: osteosarcoma

    Claudia Maier
    Department of Chemistry, Biomolecular Mass Spectrometry

    Research Interest: cancer proteomics

    Kathryn A. Higley
    Department Head
    Nuclear Engineering and Radiation Physics
    Research Interest: linear accelerator development, radiation dosimetry

    Mark Leid
    College of Pharmacy
    Research Interest: retinoic acid (RAR) and retinoid X (RXR) receptors     

    Oregon Health & Science University

    Brian J. Druker

    Charles R. Thomas, Jr.
    Radiation Medicine
    Research Interest: radiation oncology

    University of Minnesota

    Jaime F. Modiano
    Perlman Professor of Oncology and Comparative Medicine Director, Animal Cancer Center
    Research Interest: angiogeneisis, malignant endothelial cell transformation (hemangiosarcoma) and cancer immunotherapy